Family Medicine · Philadelphia, PA
NPI
1073781621
Since 2008
Specialty
Family Medicine
Code 207Q00000X
Group practices
5
Medicare group memberships
Hospitals
2
Hospital affiliations
3353 Cottman Ave
Philadelphia, PA, 19149
Phone (215) 332-4410
Groups this clinician bills Medicare through
Medicare paid, 2024
$133K
2,017 services
Medicare patients, 2024
186
Average age 72
Drug cost, 2024
$1.6M
19,599 prescriptions
Company payments, 2025
$602
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel Y Lin was code 99213 (office e&m - established), 1,224 times for 180 patients. In total Daniel Y Lin billed 2,017 services in 36 codes, and Medicare paid $133K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-06-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,224 | 180 | $66.05 | $81K |
| 99214 Office E&M - Established | Office | 391 | 137 | $94.22 | $37K |
| 36415 Venipuncture Blood Collection | Office | 53 | 45 | $8.62 | $457 |
| 93000 Electrocardiogram | Office | 52 | 46 | $10.70 | $556 |
| 96372 Injection Administration | Office | 42 | 20 | $10.64 | $447 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 38 | 18 | $0.96 | $36.46 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 36 | 36 | $132.55 | $4,772 |
| G0403 Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 26 | 26 | $10.80 | $281 |
| 83013 Clinical Chemistry | Office | 20 | 20 | $66.01 | $1,320 |
| 90471 Vaccine Administration | Office | 18 | 16 | $13.95 | $251 |
| G0008 Administration of influenza virus vaccine | Office | 18 | 18 | $29.40 | $529 |
| 81002 Clinical Chemistry | Office | 15 | 12 | $3.41 | $51.15 |
| 99204 Office E&M - New | Office | 12 | 12 | $114.95 | $1,379 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 11 | 11 | $19.19 | $211 |
By year: 2022 $132K for 2,136 services; 2023 $134K for 2,252 services; 2024 $133K for 2,017 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 53 | 45 | $8.62 | $457 |
| 83013 Clinical Chemistry | 20 | 20 | $66.01 | $1,320 |
| 81002 Clinical Chemistry | 15 | 12 | $3.41 | $51.15 |
Medicare prescription drug claims, 2024
In 2024, the drug Daniel Y Lin prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,062 prescriptions and refills. In total Daniel Y Lin wrote 19,599 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,062 | 2,527 | 302 | $6,690 |
| Amlodipine Besylate Generic | 866 | 2,033 | 225 | $3,422 |
| Simvastatin Generic | 780 | 1,865 | 212 | $4,146 |
| Losartan Potassium Generic | 673 | 1,628 | 188 | $4,199 |
| Metformin Hcl Generic | 601 | 1,423 | 161 | $2,681 |
| Tamsulosin Hcl Generic | 591 | 1,429 | 168 | $6,693 |
| Alendronate Sodium Generic | 562 | 1,291 | 153 | $3,616 |
| Donepezil Hcl Generic | 532 | 624 | 96 | $1,157 |
| Meloxicam Generic | 496 | 512 | 240 | $613 |
| Diclofenac Sodium Generic | 476 | 476 | 213 | $17K |
| Januvia Sitagliptin Phosphate | 475 | 746 | 98 | $411K |
| Omeprazole Generic | 436 | 686 | 135 | $2,224 |
| Lisinopril Generic | 411 | 985 | 104 | $1,516 |
| Vascepa Icosapent Ethyl | 382 | 654 | 104 | $196K |
| Metformin Hcl Er Metformin Hcl | 368 | 789 | 93 | $4,994 |
Brand drugs: 2,095 claims; generic drugs: 17,242 claims; opioid claims: 77.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel Y Lin $602 ($602 in general payments such as food, travel and fees) from 16 companies. The largest payer was Sumitomo Pharma America, Inc. with $109.
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. 4506.T | 6 | $109 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $71.59 |
| Gilead Sciences, Inc. GILD | 4 | $71.38 |
| Exact Sciences Corporation EXAS | 3 | $60.61 |
| Amgen Inc. AMGN | 2 | $44.5 |
| ANI Pharmaceuticals, Inc. ANIP | 2 | $43.21 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $24.49 |
| Phathom Pharmaceuticals, Inc. PHAT | 1 | $24.11 |
| Pharmacosmos Therapeutics Inc. | 1 | $23.08 |
| Abbvie Inc. ABBV | 1 | $22.31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.